Clinical Trial Update: Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients(REPAIRS) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating rosuvastatin for prognosis in acute ischemic stroke patients; the study status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Second Affiliated Hospital of Soochow University | Conditions: Infarction, Anterior Cerebral Artery | Phase 4 | Status: UNKNOWN